Curated Wealth Partners LLC Buys Shares of 2,521 HealthEquity, Inc. (NASDAQ:HQY)

Curated Wealth Partners LLC purchased a new position in shares of HealthEquity, Inc. (NASDAQ:HQY) during the 4th quarter, HoldingsChannel.com reports. The fund purchased 2,521 shares of the company’s stock, valued at approximately $242,000.

A number of other hedge funds have also recently modified their holdings of HQY. Envestnet Asset Management Inc. grew its stake in shares of HealthEquity by 7.1% in the 2nd quarter. Envestnet Asset Management Inc. now owns 115,614 shares of the company’s stock valued at $9,966,000 after buying an additional 7,645 shares during the period. Renaissance Technologies LLC acquired a new stake in HealthEquity during the second quarter worth $4,741,000. Canada Pension Plan Investment Board acquired a new position in shares of HealthEquity in the 2nd quarter valued at $465,000. Bank of Montreal Can grew its holdings in shares of HealthEquity by 10.5% during the 2nd quarter. Bank of Montreal Can now owns 11,308 shares of the company’s stock worth $976,000 after purchasing an additional 1,077 shares during the period. Finally, Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of HealthEquity during the 2nd quarter worth about $73,000. Hedge funds and other institutional investors own 99.55% of the company’s stock.

HealthEquity Price Performance

Shares of HQY opened at $106.88 on Friday. The firm has a market capitalization of $9.26 billion, a price-to-earnings ratio of 98.06, a PEG ratio of 1.86 and a beta of 0.54. The firm’s fifty day simple moving average is $99.60 and its 200-day simple moving average is $87.35. HealthEquity, Inc. has a twelve month low of $65.01 and a twelve month high of $107.87. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings results on Monday, December 9th. The company reported $0.59 earnings per share for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same period last year, the firm earned $0.40 earnings per share. Equities analysts forecast that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

Insider Buying and Selling

In other HealthEquity news, Director Robert W. Selander sold 8,250 shares of the firm’s stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $101.56, for a total transaction of $837,870.00. Following the transaction, the director now owns 66,469 shares of the company’s stock, valued at approximately $6,750,591.64. This trade represents a 11.04 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Stuart B. Parker sold 25,000 shares of the business’s stock in a transaction dated Thursday, December 12th. The shares were sold at an average price of $96.72, for a total value of $2,418,000.00. Following the completion of the sale, the director now directly owns 19,061 shares of the company’s stock, valued at $1,843,579.92. The trade was a 56.74 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 34,289 shares of company stock worth $3,355,718 over the last 90 days. 2.20% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the stock. Royal Bank of Canada increased their target price on shares of HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research note on Tuesday, December 10th. The Goldman Sachs Group assumed coverage on HealthEquity in a research report on Friday, November 15th. They set a “neutral” rating and a $108.00 price target for the company. JMP Securities boosted their price objective on HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a report on Tuesday, December 10th. Bank of America lifted their target price on HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a research report on Wednesday, November 13th. Finally, BTIG Research increased their price target on shares of HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a research report on Thursday, November 14th. One equities research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $110.71.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.